Neurological Disorder Diagnostics Market, By Technology, By Disease Indication, By End User, By Geography
상품코드:1935221
리서치사:Coherent Market Insights
발행일:2026년 01월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
신경질환 진단 시장은 2026년에 137억 6,000만 달러로 추정되며, 2033년까지 158억 7,000만 달러에 이를 것으로 예측됩니다. 2026-2033년 연평균 복합 성장률(CAGR)은 9.1%로 전망됩니다.
보고서 커버 범위
보고서 상세
기준 연도 :
2025년
2026년 시장 규모 :
137억 6,000만 달러
과거 데이터 대상 기간 :
2020-2024년
예측 기간 :
2026-2033년
예측 기간(2026-2033년) CAGR :
9.10%
2033년 예측 :
158억 7,000만 달러
신경질환 진단 도구는 알츠하이머병, 파킨슨병, 헌팅턴병 등 다양한 신경질환의 진단에 사용됩니다. 신경질환은 영상진단 기술이나 체외진단 기술을 이용하여 진단할 수 있습니다. 영상진단 기술로는 컴퓨터단층촬영(CT), 자기공명영상법(MRI) 등이 사용되며, 장기, 뼈, 연부조직, 혈관, 기타 신체 부위의 상세한 영상을 생성합니다. 한편 체외 진단 기술에는 생검, 바이오마커 검사, 혈액 검사, 소변 검사, 유전자 검사 등이 있습니다.
시장 역학
신경질환 진단기기의 기술 혁신과 개발이 시장 성장을 견인할 것으로 예측됩니다. 예를 들어, 2017년 Neusoft Medical Systems는 혁신적인 CT 스캐너 'NeuViz Prime CT Scanner'를 개발하여 미국 식품의약국(FDA)의 승인을 받았습니다. 또한 2016년에는 Koninklijke Philips N.V.사가 캐나다에서 'IQon Spectral CT'를 출시하였습니다. IQon Spectral CT는 스펙트럼 이미징 전용으로 설계된 스펙트럼 검출기 CT입니다.
본 조사의 주요 특징
이 보고서는 2018년을 기준 연도로 하여 예측 기간(2019-2027년) 시장 규모와 예측 기간(2019-2027년)의 연평균 성장률(CAGR)을 제시하는 세계 신경 질환 진단 시장에 대한 상세한 분석을 제공합니다.
또한, 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명할 것입니다.
시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보를 제공합니다.
이 보고서는 기업 개요, 재무 실적, 제품 포트폴리오, 시장 점유율, 유통 전략, 주요 개발, 전략, 미래 계획 등 다양한 매개 변수를 기반으로 세계 신경 질환 진단 시장의 주요 기업 프로파일을 제공합니다.
이 보고서는 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
이 세계 신경 질환 진단 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 신경질환 진단 시장 분석에 사용된 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 신경질환 진단 시장 : 기술별, 2026-2033년
제5장 세계의 신경질환 진단 시장 : 질환별, 2026-2033년
제6장 세계의 신경질환 진단 시장 : 최종사용자별, 2026-2033년
제7장 세계의 신경질환 진단 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 애널리스트 추천 사항
제10장 섹션
LSH
영문 목차
영문목차
Neurological Disorder Diagnostics Market is estimated to be valued at USD 13.76 Bn in 2026 and is expected to reach USD 15.87 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033.
Report Coverage
Report Details
Base Year:
2025
Market Size in 2026:
USD 13.76 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2026 To 2033
Forecast Period 2026 to 2033 CAGR:
9.10%
2033 Value Projection:
USD 15.87 Bn
Neurological disorder diagnostic tools are used for the diagnosis of various neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease and others. Neurological disorders can be diagnosed with the use of imaging and in vitro diagnostic techniques. Imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) are used to create detailed images of organs, bones, soft tissue, blood vessels, and other parts of body. Whereas, in-vitro diagnostic techniques include biopsy, biomarker, blood test, urine test, and genetic testing.
Market Dynamics
Technological innovations and developments in neurological disorder diagnosing devices are expected to drive the market growth. For instance, in 2017, Neusoft Medical Systems developed an innovative CT scanner NeuViz Prime CT Scanner and received the U.S. Food and Drug Administration approval for the system. Moreover in 2016, Koninklijke Philips N.V. launched IQon Spectral CT in Canada. IQon Spectral CT is a spectral detector CT, designed specifically for spectral imaging.
Key features of the study
This report provides in-depth analysis of the global neurological disorder diagnostics market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019-2027), considering 2018 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neurological disorder diagnostics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems, and Canon Medical Systems Corporation
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology upgradation, market expansion, and marketing tactics
The global neurological disorder diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurological disorder diagnostics market
Market Segmentation
By Technology
Imaging
In Vitro Diagnostics
By Disease Indication
Genetic Neurological Disorders
Immunological Neurological Disorders
Paraneoplastic Syndrome
Paraproteinemic Neuropathies
Others
By End User
Hospitals & Clinics
Diagnostic Centers
Ambulatory Care Centers
By Regional Insights
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Siemens Healthineers
Koninklijke Philips N.V.
General Electric Company
Esaote SpA
NeuroLogica Corporation
Masimo Corporation
York Instruments Ltd.
Neusoft Medical Systems
Canon Medical Systems Corporation
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Technology
Market Snippet, By Disease Indication
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
PEST Analysis
PORTER's Five Forces Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend
4. Global Neurological Disorder Diagnostics Market, By Technology, 2026-2033, (USD Bn)
Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Imaging
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
In Vitro Diagnostics
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
5. Global Neurological Disorder Diagnostics Market, By Disease Indication, 2026-2033, (USD Bn)
Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Genetic Neurological Disorders
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Immunological Neurological Disorders
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Paraneoplastic Syndrome
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Paraproteinemic Neuropathies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Others
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
6. Global Neurological Disorder Diagnostics Market, By End User, 2026-2033, (USD Bn)
Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Hospitals & Clinics
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Diagnostics Centers
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Ambulatory Care Centers
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
7. Global Neurological Disorder Diagnostics Market, By Region, 2026-2033, (USD Bn)
Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
U.S.
Canada
Latin America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
